Ralph J. Abi‐Habib

1.1k total citations
32 papers, 857 citations indexed

About

Ralph J. Abi‐Habib is a scholar working on Molecular Biology, Biotechnology and Genetics. According to data from OpenAlex, Ralph J. Abi‐Habib has authored 32 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Biotechnology and 10 papers in Genetics. Recurrent topics in Ralph J. Abi‐Habib's work include Cancer Research and Treatments (11 papers), Virus-based gene therapy research (7 papers) and Bacillus and Francisella bacterial research (7 papers). Ralph J. Abi‐Habib is often cited by papers focused on Cancer Research and Treatments (11 papers), Virus-based gene therapy research (7 papers) and Bacillus and Francisella bacterial research (7 papers). Ralph J. Abi‐Habib collaborates with scholars based in Lebanon, United States and France. Ralph J. Abi‐Habib's co-authors include Mirvat El‐Sibai, Arthur E. Frankel, Stephen H. Leppla, Shihui Liu, Everett Stone, Thomas Bugge, Nicholas S. Duesbery, Mohamad A. Mikati, Ghassan Dbaibo and Marwan El Sabban and has published in prestigious journals such as Blood, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Ralph J. Abi‐Habib

30 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph J. Abi‐Habib Lebanon 18 419 239 169 159 125 32 857
Stephen M. Stribbling United Kingdom 18 655 1.6× 169 0.7× 150 0.9× 278 1.7× 177 1.4× 25 1.0k
Wouter W. Kallemeijn Netherlands 27 1.1k 2.5× 197 0.8× 77 0.5× 217 1.4× 63 0.5× 48 2.0k
Steve K. Cho United States 19 542 1.3× 56 0.2× 128 0.8× 367 2.3× 118 0.9× 36 1.2k
Amor Hajri France 19 378 0.9× 135 0.6× 138 0.8× 346 2.2× 163 1.3× 34 1.0k
Omar Tounekti France 12 456 1.1× 359 1.5× 85 0.5× 146 0.9× 102 0.8× 18 1.1k
Anne Shilkaitis United States 19 688 1.6× 196 0.8× 133 0.8× 467 2.9× 164 1.3× 35 1.2k
Iring Heisler Germany 14 707 1.7× 122 0.5× 368 2.2× 242 1.5× 47 0.4× 22 1.2k
Anabel Sorolla Spain 22 791 1.9× 85 0.4× 187 1.1× 262 1.6× 100 0.8× 49 1.3k
Cholpon S. Djuzenova Germany 20 657 1.6× 172 0.7× 262 1.6× 182 1.1× 38 0.3× 41 1.1k
Fanny Norris Denmark 14 789 1.9× 166 0.7× 67 0.4× 121 0.8× 174 1.4× 17 1.5k

Countries citing papers authored by Ralph J. Abi‐Habib

Since Specialization
Citations

This map shows the geographic impact of Ralph J. Abi‐Habib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph J. Abi‐Habib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph J. Abi‐Habib more than expected).

Fields of papers citing papers by Ralph J. Abi‐Habib

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph J. Abi‐Habib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph J. Abi‐Habib. The network helps show where Ralph J. Abi‐Habib may publish in the future.

Co-authorship network of co-authors of Ralph J. Abi‐Habib

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph J. Abi‐Habib. A scholar is included among the top collaborators of Ralph J. Abi‐Habib based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph J. Abi‐Habib. Ralph J. Abi‐Habib is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaafari, Nématollah, et al.. (2025). Key genes altered in glioblastoma based on bioinformatics (Review). Oncology Letters. 29(5). 1–16.
2.
Atat, Oula El, Zahra Farzaneh, Mahsa Pourhamzeh, et al.. (2021). 3D modeling in cancer studies. Human Cell. 35(1). 23–36. 51 indexed citations
3.
4.
Fakhoury, Isabelle, et al.. (2020). Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells. Human Cell. 34(1). 152–164. 7 indexed citations
5.
Abi‐Habib, Ralph J., et al.. (2020). Arginine deprivation: a potential therapeutic for cancer cell metastasis? A review. Cancer Cell International. 20(1). 150–150. 84 indexed citations
6.
Abi‐Habib, Ralph J., et al.. (2019). [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells. Investigational New Drugs. 38(5). 1236–1246. 17 indexed citations
7.
El‐Sibai, Mirvat, et al.. (2019). Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent. Investigational New Drugs. 38(1). 10–19. 34 indexed citations
8.
9.
Liu, Shihui, et al.. (2016). Targeting the MAP kinase pathway in astrocytoma cells using a recombinant anthrax lethal toxin as a way to inhibit cell motility and invasion. International Journal of Oncology. 48(5). 1913–1920. 23 indexed citations
10.
Daher, Costantine F., et al.. (2015). Wild Carrot Oil Extract is Selectively Cytotoxic to Human Acute Myeloid Leukemia Cells. Asian Pacific Journal of Cancer Prevention. 16(2). 761–767. 25 indexed citations
11.
Stone, Everett, et al.. (2015). Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. Journal of Neuro-Oncology. 122(1). 75–85. 51 indexed citations
12.
Ghanem, Hady, Marwan Ghosn, Selim Nasser, et al.. (2015). Phospho-MEK1/2 and uPAR Expression Determine Sensitivity of AML Blasts to a Urokinase-Activated Anthrax Lethal Toxin (PrAgU2/LF). Translational Oncology. 8(5). 347–357. 10 indexed citations
13.
Stone, Everett, et al.. (2014). 765: Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells. European Journal of Cancer. 50. S184–S184. 2 indexed citations
14.
15.
16.
17.
Mikati, Mohamad A., Michele Zeinieh, Ralph J. Abi‐Habib, et al.. (2008). Changes in sphingomyelinases, ceramide, Bax, Bcl2, and caspase-3 during and after experimental status epilepticus. Epilepsy Research. 81(2-3). 161–166. 24 indexed citations
18.
Browning, Jeffrey L., Ralph J. Abi‐Habib, Simon A. Williams, et al.. (2007). Recombinant prostate-specific antigen proaerolysin shows selective protease sensitivity and cell cytotoxicity. Anti-Cancer Drugs. 18(7). 809–816. 12 indexed citations
19.
Abi‐Habib, Ralph J., et al.. (2005). BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin. Molecular Cancer Therapeutics. 4(9). 1303–1310. 57 indexed citations
20.
Mikati, Mohamad A., Ralph J. Abi‐Habib, Marwan El Sabban, et al.. (2003). Hippocampal Programmed Cell Death after Status Epilepticus: Evidence for NMDA‐Receptor and Ceramide‐Mediated Mechanisms. Epilepsia. 44(3). 282–291. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen M. Stribbling Breakdown of academic impact, for papers by Wouter W. Kallemeijn Breakdown of academic impact, for papers by Steve K. Cho Breakdown of academic impact, for papers by Amor Hajri Breakdown of academic impact, for papers by Omar Tounekti Breakdown of academic impact, for papers by Anne Shilkaitis Breakdown of academic impact, for papers by Iring Heisler Breakdown of academic impact, for papers by Anabel Sorolla Breakdown of academic impact, for papers by Cholpon S. Djuzenova Breakdown of academic impact, for papers by Fanny Norris
Rankless by CCL
2026